← Back to all trials
Recruiting
NCT05693740
Accelerated Corneal Collagen Crosslinking Protocols
Conditions: Keratoconus
Sex: All
Ages: 18 Years – 40 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 40
Sponsor: Assiut University
Location: Egypt
Summary
To evaluate and compare the effect of pulsed light (pl-ACXL) accelerated and continuous light accelerated (cl-ACXL) epithelium-off cross-linking in halting the progression of keratoconus.
Eligibility Criteria
Inclusion Criteria:Patients with mild to moderate progressive keratoconus with maximum keratometry value Kmax < 56.0 D, Corneal thinnest pachymetry ≥ 400 µm and Corrected distance visual acuity (CDVA) equal to or better than 20/200 Snellen's acuity.Established keratoconus progression:Increase of 1.0D or more in the manifest cylinder Increase of 0.5D or more in the manifest refraction spherical equivalent Increase of 1.0D or more in Kmax Increase of 0.75D or more in Kmean decrease of 2% or more in central thicknessAge: 18-40 yClear corneaExclusion Criteria:Corneal scarringPrevious corneal surgerySevere keratoconus wit non measurable refraction or Kmax ≥ 56 D or Corneal thinnest pachymetry < 400 µm
Source: ClinicalTrials.gov (NCT05693740). StuddyBuddy aggregates publicly available trial information.
